Japan attracting Korean biotech, healthcare companies

 24-Nov-16, Business Korea

South Korean biotech and healthcare companies are rapidly expanding their business in Japan. 

Image: Business Korea

For example:

• Macrogen recently established Macrogen Japan in Kyoto to provide a genome analysis service
• Medipost set up a joint venture in Japan to release its stem cell therapy product Cartistem
• MediTox is supplying anti-aging products in the Japanese market via MDT International
• Tego Science exhibited its anti-wrinkle cell therapy product TPX-105 in this year’s Bio Japan

Japan implemented a new law regarding regenerative medicine in 2015 so that cells used for regenerative medicine purposes can be authorized even without three-phase clinical trials once their safety is confirmed.

 Read the full article  

 Insights